These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 18562017)
1. Morphine suppresses intracellular interferon-alpha expression in neuronal cells. Wan Q; Wang X; Wang YJ; Song L; Wang SH; Ho WZ J Neuroimmunol; 2008 Aug; 199(1-2):1-9. PubMed ID: 18562017 [TBL] [Abstract][Full Text] [Related]
2. Morphine upregulates functional expression of neurokinin-1 receptor in neurons. Wan Q; Douglas SD; Wang X; Kolson DL; O'Donnell LA; Ho WZ J Neurosci Res; 2006 Nov; 84(7):1588-96. PubMed ID: 16983662 [TBL] [Abstract][Full Text] [Related]
3. A non-peptide substance P antagonist (CP-96,345) inhibits morphine-induced NF-kappa B promoter activation in human NT2-N neurons. Wang X; Douglas SD; Commons KG; Pleasure DE; Lai J; Ho C; Bannerman P; Williams M; Ho W J Neurosci Res; 2004 Feb; 75(4):544-53. PubMed ID: 14743438 [TBL] [Abstract][Full Text] [Related]
4. Morphine enhances hepatitis C virus (HCV) replicon expression. Li Y; Zhang T; Douglas SD; Lai JP; Xiao WD; Pleasure DE; Ho WZ Am J Pathol; 2003 Sep; 163(3):1167-75. PubMed ID: 12937158 [TBL] [Abstract][Full Text] [Related]
5. Morphine negatively regulates interferon-gamma promoter activity in activated murine T cells through two distinct cyclic AMP-dependent pathways. Wang J; Barke RA; Charboneau R; Loh HH; Roy S J Biol Chem; 2003 Sep; 278(39):37622-31. PubMed ID: 12842891 [TBL] [Abstract][Full Text] [Related]
6. Morphine inhibits intrahepatic interferon- alpha expression and enhances complete hepatitis C virus replication. Li Y; Ye L; Peng JS; Wang CQ; Luo GX; Zhang T; Wan Q; Ho WZ J Infect Dis; 2007 Sep; 196(5):719-30. PubMed ID: 17674315 [TBL] [Abstract][Full Text] [Related]
7. Effects of mu, delta and kappa opioid antagonists on the depression of a C-fiber reflex by intrathecal morphine and DAGO in the rat. Guirimand F; Strimbu-Gozariu M; Willer JC; Le Bars D J Pharmacol Exp Ther; 1994 Jun; 269(3):1007-20. PubMed ID: 7912273 [TBL] [Abstract][Full Text] [Related]
8. Morphine withdrawal enhances hepatitis C virus replicon expression. Wang CQ; Li Y; Douglas SD; Wang X; Metzger DS; Zhang T; Ho WZ Am J Pathol; 2005 Nov; 167(5):1333-40. PubMed ID: 16251417 [TBL] [Abstract][Full Text] [Related]
9. The NMDA receptor antagonist MK-801 differentially modulates mu and kappa opioid actions in spinal cord in vitro. Feng J; Kendig JJ Pain; 1996 Aug; 66(2-3):343-9. PubMed ID: 8880858 [TBL] [Abstract][Full Text] [Related]
10. The opioid antagonist, beta-funaltrexamine, inhibits chemokine expression in human astroglial cells. Davis RL; Buck DJ; Saffarian N; Stevens CW J Neuroimmunol; 2007 May; 186(1-2):141-9. PubMed ID: 17475341 [TBL] [Abstract][Full Text] [Related]
11. Increase in diazepam binding inhibitor expression by sustained morphine exposure is mediated via mu-opioid receptors in primary cultures of mouse cerebral cortical neurons. Shibasaki M; Katsura M; Torigoe F; Honda T; Sumimoto A; Tsujimura A; Ohkuma S J Neurosci Res; 2007 Oct; 85(13):2971-80. PubMed ID: 17638297 [TBL] [Abstract][Full Text] [Related]
12. In vivo pharmacological resultant analysis reveals noncompetitive interactions between opioid antagonists in the rat tail-withdrawal assay. Walker EA Br J Pharmacol; 2006 Dec; 149(8):1071-82. PubMed ID: 17075571 [TBL] [Abstract][Full Text] [Related]
13. Morphine inhibits CD8+ T cell-mediated, noncytolytic, anti-HIV activity in latently infected immune cells. Wang X; Tan N; Douglas SD; Zhang T; Wang YJ; Ho WZ J Leukoc Biol; 2005 Sep; 78(3):772-6. PubMed ID: 16000393 [TBL] [Abstract][Full Text] [Related]
14. Comparison of the opioid receptor antagonist properties of naltrexone and 6 beta-naltrexol in morphine-naïve and morphine-dependent mice. Divin MF; Holden Ko MC; Traynor JR Eur J Pharmacol; 2008 Mar; 583(1):48-55. PubMed ID: 18275956 [TBL] [Abstract][Full Text] [Related]
15. The effects of morphine on carrageenin-induced spinal c-Fos expression are completely blocked by beta-funaltrexamine, a selective mu-opioid receptor antagonist. Honoré P; Buritova J; Besson JM Brain Res; 1996 Sep; 732(1-2):242-6. PubMed ID: 8891291 [TBL] [Abstract][Full Text] [Related]
16. Chronic exposure to morphine decreases the expression of EAAT3 via opioid receptors in hippocampal neurons. Guo M; Cao D; Zhu S; Fu G; Wu Q; Liang J; Cao M Brain Res; 2015 Dec; 1628(Pt A):40-9. PubMed ID: 25839761 [TBL] [Abstract][Full Text] [Related]
17. Kappa-opioid receptors on lymphocytes of a human lymphocytic cell line: morphine-induced up-regulation as evidenced by competitive RT-PCR and indirect immunofluorescence. Suzuki S; Chuang LF; Doi RH; Bidlack JM; Chuang RY Int Immunopharmacol; 2001 Sep; 1(9-10):1733-42. PubMed ID: 11562065 [TBL] [Abstract][Full Text] [Related]
18. Nuclear receptor activation and interaction with morphine. Royal W; Leander M; Chen YE; Major EO; Bissonnette RP J Neuroimmunol; 2004 Dec; 157(1-2):61-5. PubMed ID: 15579281 [TBL] [Abstract][Full Text] [Related]
19. Activation of c-fos expression in hypothalamic nuclei by mu- and kappa-receptor agonists: correlation with catecholaminergic activity in the hypothalamic paraventricular nucleus. Laorden ML; Castells MT; Martínez MD; Martínez PJ; Milanés MV Endocrinology; 2000 Apr; 141(4):1366-76. PubMed ID: 10746640 [TBL] [Abstract][Full Text] [Related]
20. The mu opioid irreversible antagonist beta-funaltrexamine differentiates the discriminative stimulus effects of opioids with high and low efficacy at the mu opioid receptor. Morgan D; Picker MJ Psychopharmacology (Berl); 1998 Nov; 140(1):20-8. PubMed ID: 9862398 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]